Evidence map›Paper›PMID 41555625›Full record

ArticleThe American journal of case reports2026

Clinical Course and Considerations of a Stage G4 Chronic Kidney Disease Patient Who Successfully Initiated Dialysis During Pregnancy and Discontinued It Postpartum.

Maki Okamoto, Taisuke Shimizu, Mariko Sato, Sachi Kijima, Sumiko Era, Takatsugu Iwashita, Akihiko Kikuchi, Yasushi Takai, Akito Maeshima, Hajime Hasegawa and 1 more

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maki OkamotoDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Taisuke ShimizuDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Mariko SatoDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Sachi KijimaCenter for Maternal-Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Sumiko EraCenter for Maternal-Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Takatsugu IwashitaDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Akihiko KikuchiCenter for Maternal-Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Yasushi TakaiDepartment of Obstetrics and Gynecology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.ORCID 0000-0002-3872-8481
Akito MaeshimaDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Hajime HasegawaDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Tomonari OgawaDepartment of Nephrology, Hypertension and Blood Purification, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.ORCID 0000-0002-5184-6335

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Pregnancy in patients with advanced chronic kidney disease (CKD) carries a high risk of complications, including preterm birth, the need for dialysis, and adverse maternal-fetal outcomes. Miscarriage is also relatively common in dialysis patients. However, there are no established guidelines regarding dialysis initiation or fluid management in pregnant women with renal failure. CASE REPORT A 41-year-old Japanese woman had been diagnosed with IgA nephropathy at age 17 following abnormal urinalysis, but subsequently discontinued medical follow-up. Later, she became pregnant and was diagnosed with CKD stage G4 at 6 weeks of gestation (estimated glomerular filtration rate: 28.2 mL/min/1.73 m²). Despite being informed of her high-risk status, she strongly wished to continue the pregnancy. Management included salt restriction, antihypertensive therapy, and close monitoring. At 31 weeks, worsening renal function and hypertension prompted the initiation of hemodialysis. Body fluid status was assessed using bioelectrical impedance analysis and the amniotic fluid index. Dialysis parameters were adjusted to avoid fetal compromise. Vaginal delivery occurred at 36 weeks. Hemodialysis was discontinued on postpartum day 6 following improvement in renal function, and both mother and infant were discharged without complications. CONCLUSIONS This case illustrates that individualized fluid control and close inpatient monitoring can enable both the continuation of pregnancy and successful dialysis withdrawal in patients with advanced CKD. Body composition monitoring may serve as a useful tool for managing fluid balance during pregnancy-related dialysis. This report contributes to the limited literature on dynamic dialysis decision-making in pregnant CKD patients.

Indexed as

Pregnancy ComplicationsRenal DialysisRenal Insufficiency, ChronicAdultFemaleHumansPostpartum PeriodPregnancy

Identifiers

PMID41555625
PMCPMC12833986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.